Heart specialists reassessing their role in Medicare Advantage networks

Across the United States, cardiologists are taking a hard look at whether remaining in Medicare Advantage networks makes sense for their practices and their patients. What once seemed like a reliable revenue stream has become a source of constant friction, with declining reimbursement rates, mounting administrative hurdles, and shifting network rules creating conditions that many heart specialists describe as unsustainable. While Australia's healthcare system differs structurally from the American model, cardiologists in Sydney, Melbourne, Brisbane, and Perth are watching these developments closely. Private health insurers Down Under create many of the same tensions with specialists, making the US experience a useful case study for clinicians and patients who want to understand where cardiovascular care might be headed.

The pressure on cardiologists comes from multiple directions at once. Payment rates have not kept pace with inflation or the rising cost of running a practice, while administrative requirements have grown more demanding with each contract year. These issues affect not just individual doctors but the broader question of how cardiovascular care reaches the millions of Australians and Americans living with heart disease.

A quick comparison of the major payer environments illustrates how these differ for cardiology practices across markets.

Feature	US Traditional Medicare	US Medicare Advantage	Australian Private Health Funds
Reimbursement basis	Fixed federal fee schedule	Negotiated plan rates, often adjusted through coding	Negotiated fees with frequent gap payments
Prior authorisation requirements	Rare for most services	Common for imaging, devices, and procedures	Common for hospital admissions and selected procedures
Network structure	Broad patient choice	Narrow networks with selective contracting	Selective credentialing across funds
Typical patient out-of-pocket	20% after deductible	Copays and coinsurance vary by plan	Gap payments vary widely by specialist

Reimbursement trends squeezing practice margins

Medicare Advantage plans, which are private insurance alternatives to traditional Medicare, have grown to cover roughly half of all Medicare-eligible Americans. Cardiologists who signed contracts with these plans years ago expected steady, predictable payments. Instead, many practices report that reimbursement rates have stagnated or been quietly reduced through changes in coding and risk adjustment. A routine echocardiogram or stress test that once paid at a certain level may now be subject to downcoding, where insurers reclassify the service to a lower-paying category.

The impact shows up in practice finances within months. Staff salaries, rent, equipment leases, and malpractice premiums continue to climb each year, but payment per procedure stays flat or falls. Several cardiology groups in the US have responded by closing satellite clinics, reducing the number of Medicare Advantage patients they accept, or simply opting out of certain networks entirely. The detailed policy overview facing cardiovascular care highlights how these financial pressures intersect with patient access.

Administrative complexity and prior authorisation demands

Beyond the dollar figure, the hidden cost of Medicare Advantage participation lies in the paperwork. Prior authorisation requirements have become routine for diagnostic tests, device implants, and even follow-up visits for patients with chronic conditions like heart failure or atrial fibrillation. A cardiologist seeking approval for an implanted loop recorder or a cardiac MRI often waits days or weeks for a response, during which the patient's condition can deteriorate.

The administrative load requires practices to hire dedicated staff whose sole job is to navigate insurer portals, submit peer-to-peer review requests, and appeal denials. For a solo practitioner in suburban Sydney or a small group in regional Queensland, this overhead can be the difference between keeping the doors open and closing them. Many Australian cardiologists already recognise the pattern because local private health funds require similar authorisation for procedures, and the burden has grown steadily over the past decade.

Network restrictions and patient access concerns

Being in a Medicare Advantage network is supposed to ensure patient access, but cardiologists report the opposite is happening in many regions. Narrow networks mean that patients may live within the plan's service area but still find that the nearest participating cardiologist is miles away, or that referring physicians outside the network cannot easily direct patients to specialists who are in. When patients do receive care, surprise out-of-network bills can arise even at in-network facilities if the specific cardiologist on call has opted out.

In Australia, similar dynamics appear when private health funds negotiate selective contracts with particular hospital cath labs or cardiology groups. A patient in Perth with a popular Bupa or Medibank policy may find that only a handful of interventional cardiologists are recognised providers, limiting choice and creating delays. These structural limits matter most for patients with complex needs, such as those requiring electrophysiology studies or transcatheter valve procedures.

Australian parallels with private health insurers

Australia does not have Medicare Advantage, but the role is effectively played by private health insurance funds that contract with specialists and hospitals. Private Healthcare Australia and member funds negotiate schedules of fees that often fall below what specialists consider fair, and patients face gap payments that can run into hundreds of dollars for a single consultation. Cardiologists in Melbourne report that gap disputes with insurers are among the most common reasons for delayed or cancelled procedures, particularly for advanced imaging and interventional work.

Federal legislation such as the Private Health Insurance Act and ongoing reviews by the Australian Competition and Consumer Commission shape how these arrangements work. The ACCC's reporting on private health insurance has repeatedly flagged concerns about value for consumers, including how specialist participation affects patient access. Cardiologists watching from Australia see the US experience with Medicare Advantage as a cautionary tale about what happens when private insurers grow too dominant in a specialist's referral base.

Workforce and burnout considerations

The cumulative effect of financial strain and administrative load is driving cardiologists out of network participation altogether, and in some cases, out of medicine entirely. Surveys of cardiovascular specialists in the US show that burnout rates have climbed steadily, with younger physicians expressing particular reluctance to enter contracts that limit their autonomy. Early-career cardiologists are choosing hospital employment, concierge models, or cash-only practices as alternatives to the traditional fee-for-service model tied to insurer contracts.

Australian cardiology faces a parallel workforce challenge. Rural and remote regions already struggle to attract heart specialists, and the administrative demands of dealing with multiple private health funds make metropolitan practice less attractive as well. The combination of high training demands, expensive equipment, and payer friction means fewer trainees view cardiology as their preferred specialty, which has long-term consequences for patient care across both countries.

What this signals for patients

When cardiologists walk away from Medicare Advantage or Australian private health fund contracts, the immediate effect falls on patients. Those with existing relationships may need to switch providers, pay higher out-of-pocket costs, or travel further for appointments. Continuity of care suffers when patients cannot see the same cardiologist who has managed their heart failure or valvular disease for years, and care quality research consistently shows that fragmented specialist access leads to worse outcomes.

Patient advocacy groups have encouraged people to share their stories about coverage denials, prior authorisation delays, and unexpected bills, building a public record of how insurance design affects cardiovascular care. Similar advocacy exists in Australia through organisations working on private health insurance reform. Resources for patients navigating complex healthcare decisions extend across many specialties, including specialised patient guides that illustrate how access and informed-consent challenges appear throughout medicine.

Looking ahead for cardiovascular care

The decisions cardiologists make about network participation over the next few years will shape cardiovascular care for a generation. If participation becomes financially or administratively untenable, more specialists will consolidate into hospital systems, fewer independent practices will survive, and patient choice will narrow. Conversely, regulatory or market changes that ease the administrative load, restore fair reimbursement, or protect network adequacy could bring cardiologists back into broader participation.

For Australian clinicians and patients, the US experience with Medicare Advantage offers a window into how rapidly specialist networks can shift when payment and policy conditions change. Watching these trends, engaging with local advocacy efforts, and supporting policy frameworks that prioritise patient access over insurer savings remain the most practical responses. Cardiovascular disease remains the leading cause of death in most developed nations, and ensuring patients can see a cardiologist when they need one is a goal that deserves sustained attention regardless of which side of the Pacific a practice sits on.